Trending Stories on Eyewire+
FDA Accepts Aldeyra's NDA for Reproxalap in Dry Eye Disease; Expands Partnership with AbbVie
Aldeyra Therapeutics announced that the FDA has officially accepted for review the resubmitted new drug application (NDA) for its topical ocular therapy, reproxalap, aimed at treating the signs and symptoms of dry eye disease. The FDA has set a Prescription Drug User Fee Act (PDUFA) target date of April 2, 2025.
In parallel with the NDA acceptance, Aldeyra has also expanded its existing exclusive option agreement with.. Read More
Adverum Announces Postive LUNA Phase 2 and OPTIC Long-Term Data on Gene Therapy for Wet AMD
Adverum Biotechnologies has released 52-week topline results from its Phase 2 LUNA trial and new 4-year follow-up data from the OPTIC Phase 1/2 study on its wet AMD gene therapy candidate Ixo-vec (AAV.7m8-aflibercept).
“We are thrilled to report 52-week LUNA data and 4-year OPTIC data that continue to support Ixo-vec as a transformative and potential best-in-class therapy, which may provide patients who have wet AMD with... Read More
Samsung Bioepis and Biogen Announce EC Approval of Eylea Biosimilar Opuviz
Samsung Bioepis and Biogen jointly announced that the European Commission (EC) has granted approval for Opuviz 40 mg/mL for injection in a vial. The biosimilar, also known as SB15, references the established treatment Eylea (aflibercept) and was developed by Samsung Bioepis. The approval covers its use in a range of retinal conditions, including... Read More
EyewireTV | 11.13.2024
Leaders in several ophthalmic companies with a focus on post the posterior segment, provide updates on their pipeline and new products in this special edition of Eyewire TV. Click here to check it out!
Latest In Podcasts
Recommended by LinkedIn
How to Add Dry Eye Research to Your Clinical Life
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by Sathi Maiti, OD, FAAO, who shares her knowledge and experience working on dry eye clinical research. Dr. Maiti offers great advice on what you need to know before seeking out a clinical trial, how to delegate tasks to your staff related to the study, tips for patient recruiting and scheduling, and other considerations. Click here to catch the latest episode.
Drafting Your Keratoconus Quarterback
In this new podcast series examining hot topics and clinical pearls for managing keratoconus, Brandon Ayres, MD, invites Priya Mathews, MD, MPH, to discuss how she fits crosslinking into her practice. Dr. Mathews explains how she appointed a member of her team to the “quarterback” position of organizing and managing the many moving parts of scheduling these patients. Catch the latest episode here!
Eyewire News: The Podcast
Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of EyewireTV. Catch the latest episodes here!
Latest in Subspecialties:
Thank you for reading! We'll be back next week with another edition of Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+.